| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2caa65b95c54b77adfc4d77fcadd8514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b9b819915783bb55a9279deb7eea990
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
1998-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65e1360830a64a698bd3e7544b274452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4904a4b0ae4cf86cf1ee9849f12b2c45 |
| publicationDate |
1999-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9927928-A1 |
| titleOfInvention |
Inhibitors of farnesyl-protein transferase |
| abstract |
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7323570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6958350-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6706888-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6903085-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6960602-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7211595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7294636-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7192973-B2 |
| priorityDate |
1997-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |